Several studies have revealed that TPR can fuse with other kinase domains of oncogenes, including TRK in human papillary thyroid carcinomas [24], FGER1 in myeloproliferative syndrome [25], and ALK in lung adenocarcinoma [26]. This evidence concerns the gene ALK and differentiated thyroid carcinoma.